Data Availability
Summary statistics of the genetic analyses from the INTERVAL and deCODE studies are publicly available online at https://ega-archive.org/datasets/EGAD00001004080/files and https://www.decode.com/summarydata/. The genetic instruments used for the main analyses are provided in Supplementary Table S1 and are available from previous publications.1,8 GWAS summary statistics for coronary artery disease and large artery stroke from the CardioGRAMPLUSC4D Consortium and the MEGASTROKE Consortium are available at http://www.cardiogramplusc4d.org/data-downloads/ and https://www.megastroke.org/download.html, respectively. GWAS summary statistics for PAD have been accessed through dbGAP (pha005161.1) with an approved application by JR and CDA for the Veterans Administration (VA) Million Veteran Program (MVP) Summary Results from Omics Studies. Summary statistics from the NSTEMI trial were accessed through contact of the corresponding authors of the study and are available to interested authors through an application and a short research proposal submitted to the study. Data from the MONICA/KORA study are not publicly available because the data are subject to national data protection laws and restrictions were imposed by the ethics committee of the Bavarian Chamber of Physicians to ensure data privacy of the study participants. However, data are available on request to researchers through a project agreement from KORA (http://epi. helmholtz-muenchen.de/kora-gen/). Requests should be sent to kora.passt{at}helmholtz-muenchen.de and are subject to approval by the KORA board. The datasets from Athero-Express analyzed for the current study are available upon reasonable request and application to Athero-Express Biobank Study through a Data Transfer Agreement due to consent restrictions and local regulations. The gene expression dataset from STARNET was accessed through dbGAP with an approved application by JR and CDA (phs001203.v1.p1). Data for the single-nuclei transcriptomic analyses were accessed through the Single Cell Portal (https://singlecell.broadinstitute.org/single_cell). The YFS is a population-based prospective follow-up study on cardiovascular risk factors in Finland. It has been carried out in all five Finnish university cities with medical schools and their rural surroundings. The first cross-sectional study was conducted in 1980. Altogether 4,320 children and adolescents aged 3, 6, 9, 12, 15 and 18 years were randomly recruited from the population register of these areas to produce a representative subsample of Finnish children. Of these individuals 3,596 (83%) participated in year 1980. Since then, regular follow-up visits have been performed in 1980, 1983, 1986, 2001, 2007, 2011 and 2018/2020. Follow-up using registry data (diagnoses, medications and mortality) have been extended by 2018. The YFS has been approved by the Joint Commission on Ethics of the Turku University and the Turku University Central Hospital and has been conducted according to the guidelines of the Declaration of Helsinki, and informed consent has been obtained from all participants or their parents.
https://ega-archive.org/datasets/EGAD00001004080/files
http://www.cardiogramplusc4d.org/data-downloads/
https://www.megastroke.org/download.html
http://epi.helmholtz-muenchen.de/kora-gen/
